688065 凱賽生物
按盤價 
47.540 +6.840 (+16.806%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.205 | 3.315 | 5.123 | 5.654 | 6.091 |
| 總資產報酬率 ROA (%) | 1.332 | 2.000 | 3.253 | 4.200 | 5.052 |
| 投入資產回報率 ROIC (%) | 1.934 | 2.923 | 4.705 | 5.449 | 5.961 | 邊際利潤分析 |
| 銷售毛利率 (%) | 31.223 | 28.794 | 35.241 | 35.629 | 46.623 |
| 營業利潤率 (%) | 19.422 | 21.488 | 29.015 | 30.605 | 34.881 |
| 息稅前利潤/營業總收入 (%) | 14.530 | 11.231 | 16.422 | 22.939 | 34.054 |
| 淨利潤/營業總收入 (%) | 16.902 | 19.324 | 25.097 | 26.804 | 30.547 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.682 | 84.925 | 101.863 | 95.545 | 89.397 |
| 價值變動淨收益/利潤總額(%) | -1.359 | -1.742 | -0.533 | 2.251 | 5.370 |
| 營業外收支淨額/利潤總額(%) | 0.126 | -1.196 | -1.766 | 0.152 | -0.277 | 償債能力分析 |
| 流動比率 (X) | 2.782 | 2.220 | 5.951 | 9.357 | 19.423 |
| 速動比率 (X) | 2.240 | 1.790 | 4.846 | 8.384 | 17.640 |
| 資產負債率 (%) | 18.731 | 21.559 | 15.645 | 9.334 | 5.362 |
| 帶息債務/全部投入資本 (%) | 7.327 | 10.872 | 6.125 | 4.177 | -1.871 |
| 股東權益/帶息債務 (%) | 1,221.420 | 791.082 | 1,478.054 | 2,232.662 | -5,333.751 |
| 股東權益/負債合計 (%) | 328.802 | 274.962 | 392.567 | 705.067 | 1,595.840 |
| 利息保障倍數 (X) | -2.955 | -1.123 | -1.358 | -2.974 | -46.654 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 34.194 | 53.949 | 47.911 | 34.077 | 41.100 |
| 存貨周轉天數 (天) | 253.256 | 363.485 | 314.122 | 231.920 | 361.559 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
